GLP-1 therapies are transforming weight management, but weight loss alone is no longer the finish line. Today’s clinical landscape demands deeper insights: Is the patient losing fat or vital muscle? Is their metabolic health actually improving?

In this webinar, leading experts from clinical research and digital health will explore the next frontier of GLP-1 innovation. Discover how continuous sensor data and multidimensional measurement—from glycemic variability to muscle quality—reveal the real-world impact traditional metrics miss.

Watch the recorded session now to learn how advanced analytics are redefining GLP-1 research and measuring what truly matters.

Featured Speakers: 

Melissa Ceruolo – VP Engineering & Analytics, Medidata

Allison Goldfine, MD – Executive Director, Translational Medicine Cardiovascular and Metabolism, Novartis

Amy E Rothberg, MD DABOM – Clinical Professor of Medicine, Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan

Robert Sala – Director Medical Affairs, Research and CRO Integration, Dexcom

Poul Strange – Medical Director, Integrated Medical Development

Lucy Cesnakova – Associate Program Director, Digital Medicine Society